This invention provides an isolated mammalian nucleic acid molecule encoding
an alternatively spliced prostate-specific membrane (PSM) antigen. This
invention provides an isolated nucleic acid molecule encoding a prostate-specific
membrane antigen promoter. This invention provides a method of detecting hematogenous
micrometastic tumor cells of a subject, and determining prostate cancer progression
in a subject.